
Joint Stock Company Grindeks is an international, vertically integrated pharmaceutical company. The main fields of action are research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. The main therapeutic groups of Grindeks are cardiovascular, central nervous system, anti-cancer and diabetes medicines.
Annual Revenue$500M to $1B
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.